Vicepresidente, Egualia Area Biosimilari - Coordinatore, IBG (Italian Biosimilars Group)
Stefano Collatina graduated in Medicine in Rome in 1987 and had his 34 years career development in Healthcare Industry, either in Italy and in the US, mostly in Multinational organizations like Bristol-Myers Squibb, Merck, Schering AG and Baxter.
Stefano is member of the Board of Egualia, the Italian Association representing the Generic Drugs Industries, and Vice-President and Chairman of the Italian Biosimilar Group. Stefano is even a member of the Board of the Hopen Foundation, a non-profit organization supporting patients and families with undiagnosed genetic disease.